Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
Dupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine portfolio, which has become the…
45,000€
-3,43%
Echtzeit-Aktienkurs Sanofi S.A. (Sp. ADRs)
Bid:
Ask:
Nachrichten zur Sanofi S.A. (Sp. ADRs) Aktie
Form 6-K Sanofi For: Oct 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…